Peer-reviewedCC BY 4.0Cell Reports
Lacticaseibacillus rhamnosus GG enhances gefitinib efficacy and reduces treatment-related toxicity via propionyl-L-carnitine regulation
Related
- Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
- Dual targeting of EGFR signaling and microtubule dynamics enhances replication-associated cellular stress and suppresses tumor growth in gefitinib-resistant non-small cell lung cancer
- Fluoxetine Hydrochloride Treatment Influences Site-Specific ADAR Editing and Transcriptome Regulation in Arid1b +/- Mice
- Assessment of antimicrobial potential of cell-free supernatant from Lacticaseibacillus paracasei SRG isolated from the vaginal microbiota of healthy women against uropathogens
- Lacticaseibacillus paracasei KW3110 induces interleukin-12 production via Toll-like receptor 8 in human macrophages and exerts immunomodulatory effects
BibTeX
@article{shen2026lacticaseibacillus,
title = {{Lacticaseibacillus rhamnosus GG enhances gefitinib efficacy and reduces treatment-related toxicity via propionyl-L-carnitine regulation}},
author = {Siyuan Shen and Xi Xie and Liting Lu and Wenyao Ma and Haiyang Tu and Jiachao Zhang},
journal = {Cell Reports},
year = {2026},
month = oct,
doi = {10.1016/j.celrep.2026.118068},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2211124726011472},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Lacticaseibacillus rhamnosus GG enhances gefitinib efficacy and reduces treatment-related toxicity via propionyl-L-carnitine regulation
AU - Siyuan Shen
AU - Xi Xie
AU - Liting Lu
AU - Wenyao Ma
AU - Haiyang Tu
AU - Jiachao Zhang
PY - 2026
DA - 2026/10/01
JO - Cell Reports
DO - 10.1016/j.celrep.2026.118068
UR - https://linkinghub.elsevier.com/retrieve/pii/S2211124726011472
SN - 2211-1247
ER -